
By Padraic Halpin DUBLIN, July 16 (Reuters) - Britain's Immunocore completed Europe's largest ever financing round by a private life sciences company on Thursday, raising $320 million from investors including Eli Lilly & Co, Malin and Woodford Investment Management. The Oxford-based b
* New drugs join price control list of more than 500 drugs * Abbott, GSK, Lupin and Ipca among firms affected (Adds details on government's position, results of new study ) By Zeba Siddiqui MUMBAI, July 16 (Reuters) - India has extended price caps to an additional 39 drugs ran
MUMBAI, July 16 (Reuters) - India has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics, in the government's latest effort to improve affordability of medicines. The move impacts multinational drugmakers, like Abbott Laboratories and GlaxoSmit
LONDON, July 14 (Reuters) - GlaxoSmithKline said on Tuesday it had forged a collaboration with the Francis Crick Institute, making it the first pharmaceutical company to link up with the new biomedical centre based in London. Named after the Nobel laureate who co-discovered the molecular st
(Adds latest statements from companies, details) By Paul Carsten and Arathy S Nair BEIJING/BENGALURU, July 10 (Reuters) - Chinese authorities have detained about half a dozen former employees of Tencent Holdings Ltd for alleged corruption and bribery, as well as a current Alibaba Grou
(Adds Alibaba statement) BEIJING, July 9 (Reuters) - Chinese authorities have detained about half a dozen former employees of Tencent Holdings Ltd, the country's biggest social network and online media company, as part of a graft investigation following an internal company probe, Tencent sa